Rafael Soriano Getty

Rafael Soriano, Michael Bourn, Nick Swisher and B.J. Upton to reject qualifying offers


Those free agents who received one-year, $13.3 million qualifying offers last week must decide by 5 p.m. ET tomorrow whether to accept them. David Ortiz finalized a two-year, $26 million extension with the Red Sox earlier this week, so that leaves eight players with a decision to make: Josh Hamilton, Rafael Soriano, Nick Swisher, Hiroki Kuroda, B.J. Upton, Kyle Lohse, Michael Bourn and Adam LaRoche.

Most believe that all eight will decline the qualifying offers, but we’ll keep track of them anyway.

Jon Heyman of CBSSports.com reports that Soriano intends to reject the qualifying offer from the Yankees. Mariano Rivera plans to return next season, so Soriano is expected to attempt to find a closer job on the open market. The Yankees will receive draft pick compensation if he signs with another club.

Another no-brainer, Scott Boras told David O’Brien of the Atlanta Journal-Constitution that Bourn will decline the qualifying offer from the Braves. The 29-year-old speedster is coming off a career year and should do very well as one of the top position players available this offseason.

Mark Feinsand of the New York Daily News reports that Swisher will reject the qualifying offer from the Yankees. He also hears that five teams have interest in Swisher, including the Rangers and Mariners. The Yankees made the qualifying offer hoping that he would reject and sign elsewhere, ensuring them a draft pick as a result, so it appears they will get their wish.

Finally, Marc Topkin of the Tampa Bay Times hears that B.J. Upton is set to decline his qualifying offer from the Rays. An easy call, as he should land a long-term deal in free agency this winter. The Rays will get a compensatory pick when he signs elsewhere. Interestingly, the Rays have been mentioned as a possible trade partner with the Diamondbacks for B.J.’s brother, Justin Upton.

Pirates expressing interest in Justin Masterson

Justin Masterson
AP Photo/Ben Margot
Leave a comment

Pirates pitching coach Ray Searage has become the king of the reclamation project. And it sounds like he’s about to take on another big one …

Travis Sawchik of the Pittsburgh Tribune-Review reports that the Pirates have expressed interest in free agent Justin Masterson. The expectation is that it will be a one-year deal with the goal of rebuilding the right-hander’s value in an environment where many other struggling veteran pitchers have executed significant career turnarounds.

Masterson earned his first (and only) All-Star nod in 2013 when he registered a 3.45 ERA, 195 strikeouts, and three shutouts in 32 appearances with the Indians. But he had a 5.88 ERA in 128 2/3 innings between Cleveland and St. Louis in 2014 and he continued struggling to the tune of a 5.61 ERA with the Red Sox in 2015.

It’s not clear whether the Bucs would try him as a starter or reliever.

Zack Greinke deal “could come soon,” Dodgers and Giants lead the bidding

Zack Greinke
AP Photo/Mark J. Terrill

Jordan Zimmermann signed with the Tigers on Sunday for five years, $110 million. David Price signed with the Red Sox on Tuesday for seven years, $217 million.

Two big dominos have fallen in this loaded free agent market for starting pitchers, and another big one is about to go …

FOX Sports’ Ken Rosenthal says a deal for Zack Greinke “could come soon” and it’s currently “Dodgers vs. Giants” at the top of the bidding ladder.

ESPN’s Jerry Crasnick confirms that both the Dodgers and Giants are looking for an answer from Greinke, adding that the 32-year-old right-hander seeks a five- or six-year deal with a greater average annual value (AAV) than what Price just secured from Boston. That number would be $31 million, so we’re talking something close to $32 million through 2020-2021.

Greinke opted out of the remaining three years and $71 million contract with Los Angeles in October after posting a 1.66 ERA and 0.84 WHIP across 222 2/3 regular-season innings in 2015. He finished second to the Cubs’ Jake Arrieta in the National League Cy Young Award balloting.

The Red Sox get their ace! Boston signs David Price to a 7-year, $217 million deal


Multiple reports circulated in the past week that the Red Sox would need to unload the money truck in order to sign David Price. Well, the truck just got unloaded: Pete Abraham of the Boston Globe reports that the Red Sox have signed David Price to a seven-year, $217 million contract.

This is, by far, the largest free agent contract the Red Sox have ever given a pitcher. It beats Max Scherzer‘s seven-year, $210 million deal signed last offseason as the largest ever free agent pitcher contract. Clayton Kershaw‘s contract extension with the Dodgers was for $215 million.

Price went 82-47 with a 3.18 ERA pitching in the AL East while with the Tampa Bay Rays. After being traded to the Tigers just before the 2014 trade deadline he went 13-8 with a 2.90 ERA in 32 starts. He returned to the AL East with the Blue Jays this year, going 9-1 with a 2.30 ERA in 11 starts. He also pitched in the playoffs for the Jays starting three times in four overall appearances.

The Red Sox were in dire need of pitching and they were said to be gunning for Price to fill that need. Target: acquired.

Major League Baseball’s annual drug testing report has been released

Leave a comment

MLB and the MLBPA just released the annual public report from the Joint Drug Prevention and Treatment Program’s Independent Program Administrator. It’s the annual report, mandated by the JDA, which says how many positive drug tests there were, what the drugs were, etc.

The notable numbers, which cover the period starting when the 2014 World Series ended until the 2015 World Series ended:

  • Total number of tests administered: 8,158. 6,536 of them were urine tests, 1,622 of them were blood tests for HGH;
  • 10 tests resulted in positives which led to discipline: 7 for PEDs, 2 for stimulants, one for DHEA;
  • The previous year there were 7,929 total tests with 12 which resulted in discipline;
  • There were the same number of Therapeutic Use Exemptions granted this year as last: 113. All but two were for attention deficit disorder. One was for gynecomastia, which is the swelling of the breast tissue in men due to a hormone imbalance, one was for a stress fracture in someone’s elbow.

A use exemption line item which had appeared on the list for the previous several years — hypogonadism — was not there, so congratulations to the anonymous player who was either cured or who retired.

As we always note, the number of players who got exemptions for ADD drugs is a bit higher than the occurrence of ADD in the population at large and, once you eliminate kids from ADHD occurrences, it’s likely considerably higher. But that’s none of my business.